Are you Dr. Vizcarrondo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Birmingham, AL 35233Phone+1 205-934-9999
Summary
- Dr. Francisco Vizcarrondo, MD is an oncologist in Birmingham, Alabama. He is currently licensed to practice medicine in Alabama. He is affiliated with University of Alabama Hospital and is a Chief at Hematology/Oncology Birmingham VA Hospital.
Education & Training
- University of Puerto RicoFellowship, Hematology and Medical Oncology, 1974 - 1976
- University of Puerto Rico School of MedicineClass of 1969
Certifications & Licensure
- AL State Medical License 1974 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- 354 citationsRovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyCharles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, Neal Ready, Daniel Morgensztern
The Lancet. Oncology. 2017-01-01 - 120 citationsPhase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naïve advanced non-small-cell lung cancerFrancisco Robert, George R. Blumenschein, Roy S. Herbst, Frank V. Fossella, Jennifer F. Tseng
Journal of Clinical Oncology. 2005-12-20 - 7 citationsSWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)Hossein Borghaei, Mary W. Redman, Karen Kelly, Saima N. Waqar, Francisco Robert
Clinical Lung Cancer. 2021-05-01